Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium
- PMID: 7120132
Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium
Abstract
A rapid superfusion system incorporating a continuous amperometric detector has been employed to study the effects of p-tyramine, d-amphetamine and cocaine on K+-stimulated release of dopamine (DA) from striatal tissue. Qualitative identification of the released substances is made by liquid chromatography with electrochemical detection and DA is established to be the principal substance released following exposure of the tissue to 60 mM K+ in the presence of Ca++. At a superfusion rate of 1 ml/min with a 20 microliter volume tissue holder, d-amphetamine and p-tyramine do not elicit detectable release of endogenous substances. These results are in direct contrast to the significant release of DA observed when striatal tissue is incubated with d-amphetamine for the same time period and suggest that the pools susceptible to release by the sympathomimetic amines are removed by superfusion. When striatal tissue is superfused with a buffer containing 60 mM K+ and cocaine or sympathomimetic amines, the effects of uptake blockade are manifested as an increase in the amount and duration of observed release over that obtained with 60 mM K+. In a competitive study of cocaine and p-tyramine with d-amphetamine, it appears that all three of these agents induce blockade at the same site(s). All of these data are in direct accord with the facilitated exchange diffusion mechanism proposed for the actions of sympathomimetic amines at DA nerve terminals.
Similar articles
-
Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.J Pharmacol Exp Ther. 1987 Jan;240(1):177-86. J Pharmacol Exp Ther. 1987. PMID: 3100768
-
Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.Synapse. 1990;5(2):157-64. doi: 10.1002/syn.890050211. Synapse. 1990. PMID: 2309159
-
The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.J Pharmacol Exp Ther. 1980 Sep;214(3):651-6. J Pharmacol Exp Ther. 1980. PMID: 6772760
-
Natural Sympathomimetic Drugs: From Pharmacology to Toxicology.Biomolecules. 2022 Nov 30;12(12):1793. doi: 10.3390/biom12121793. Biomolecules. 2022. PMID: 36551221 Free PMC article. Review.
-
The vascular effects of trace amines and amphetamines.Pharmacol Ther. 2010 Mar;125(3):363-75. doi: 10.1016/j.pharmthera.2009.11.005. Epub 2009 Dec 4. Pharmacol Ther. 2010. PMID: 19948186 Review.
Cited by
-
Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.J Neural Transm. 1987;70(3-4):217-32. doi: 10.1007/BF01253599. J Neural Transm. 1987. PMID: 3119772
-
Release of 3H-dopamine and analogous monoamines from rat striatal tissue.Cell Mol Neurobiol. 1988 Jun;8(2):205-16. doi: 10.1007/BF00711246. Cell Mol Neurobiol. 1988. PMID: 3409267 Free PMC article.
-
How addictive drugs disrupt presynaptic dopamine neurotransmission.Neuron. 2011 Feb 24;69(4):628-49. doi: 10.1016/j.neuron.2011.02.010. Neuron. 2011. PMID: 21338876 Free PMC article. Review.
-
Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.J Neural Transm (Vienna). 2001;108(2):141-51. doi: 10.1007/s007020170084. J Neural Transm (Vienna). 2001. PMID: 11314769
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical